Athena Capital (South Africa)
Athena Capital (Pty) Ltd is a venture capital and private equity firm based in Cape Town, South Africa, with additional offices in Johannesburg and London. Established in 2003, the firm specializes in investments across various stages, including early-stage and middle-market acquisitions, with a particular focus on sectors such as energy and resources, financial services, agribusiness, and manufacturing. Athena Capital primarily targets opportunities in Sub-Saharan Africa, Europe, and Scandinavia, seeking platform companies that can leverage government and development finance support. The firm aims to secure board representation in its portfolio companies and is also involved in financial advisory services, offering transaction advisory for private equity, mezzanine debt, and trade finance. The firm has an established track record and a clear focus on sectors that align with its investment strategy.
BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.
ComboCap Health
Private Equity Round in 2017
ComboCap is a technology company that operates within the pharmaceutical and nutraceutical sectors, focusing on the development of innovative health products. It specializes in dual-delivery systems, offering a unique dual-chamber oral capsule designed with a movable membrane. This design allows for enhanced bioavailability and stability, making it suitable for dietary supplements, pharmaceuticals, and biopharmaceuticals. By enabling the combination of various substances, ComboCap provides clients with the ability to create effective combination therapies and over-the-counter products, thereby addressing diverse health needs in the market.
Nurevas
Private Equity Round in 2011
Nurevas is a food processing company engaged in the manufacturing and marketing of a diverse range of processed food products. The business focuses on serving both the retail and catering sectors, producing a variety of items such as sauces, condiments, spreads, mayonnaise, and tomato-based products. Nurevas aims to provide consumers with healthy and safe food options at affordable prices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.